AFP Calculator – Alpha-Fetoprotein Unit Converter

Alpha-Fetoprotein (AFP) Unit Converter

Convert AFP laboratory values between different concentration units instantly. Enter your value and select the unit to see conversions across all common formats.

How to Use This Converter

Getting your AFP results from different labs can be confusing when they use different units. This converter helps you compare values across different measurement systems.

Quick Start Steps

Step 1: Locate the AFP value on your lab report
Step 2: Note which unit is being used (usually ng/mL or IU/mL)
Step 3: Enter the number in the input field above
Step 4: Select your current unit from the dropdown
Step 5: Click “Convert Units” to see all equivalent values
Pro Tip: Save this page for future reference when comparing lab results from different time periods or facilities.

What is Alpha-Fetoprotein?

Alpha-fetoprotein is a protein produced primarily by the liver and yolk sac of a developing fetus. In adults, AFP levels are typically very low. Measuring AFP serves several important medical purposes.

Clinical Applications

AFP testing is used in three main scenarios. During pregnancy, it helps screen for neural tube defects and chromosomal abnormalities in the developing baby. For cancer monitoring, elevated AFP levels can indicate certain types of tumors, particularly hepatocellular carcinoma and germ cell tumors. In liver disease management, AFP tracking helps assess disease progression and treatment response.

Why Different Units Exist

Different countries and laboratories have adopted various measurement systems over time. Some facilities use mass-based concentrations like ng/mL, while others prefer activity-based units like IU/mL. This variation stems from different standardization approaches in clinical chemistry. Having a reliable converter becomes essential when your results need to be compared across different labs or when discussing values with specialists who may use different units.

Conversion Formulas Explained

The calculator uses scientifically established conversion factors. Here’s how the math works behind the scenes.

From ng/mL to IU/mL

ng/mL × 0.83 = IU/mL

Example: 50 ng/mL × 0.83 = 41.5 IU/mL

From IU/mL to ng/mL

IU/mL × 1.21 = ng/mL

Example: 100 IU/mL × 1.21 = 121 ng/mL

Unit Equivalencies

1 ng/mL = 1 µg/L = 1,000 ng/L

1 ng/dL = 1 ng/100mL = 1 ng%

1 ng/mL = 100 ng/dL

Why These Specific Factors?

The conversion between ng/mL and IU/mL isn’t a simple round number because these units measure different properties. The ng/mL measures actual mass, while IU/mL measures biological activity. The 0.83 and 1.21 factors come from international standards that define how much biological activity corresponds to a given mass of AFP.

Reference Ranges

What counts as a normal AFP level depends on several factors. Let’s break down what the numbers typically mean.

Population Normal Range Unit Notes
Adult Men 0 – 10 ng/mL May vary by age and ethnicity
Non-pregnant Women 0 – 10 ng/mL Baseline adult level
Pregnant Women (2nd trimester) 15 – 60 ng/mL Peaks around week 30-32
Hepatocellular Carcinoma > 400 ng/mL Significantly elevated
Liver Metastases < 350 ng/mL Moderately elevated
Important: These ranges are general guidelines only. Your specific reference range depends on the laboratory method used, your age, pregnancy status, and other individual factors. Always interpret results with your healthcare provider.

What Elevated Levels May Indicate

Higher than normal AFP doesn’t automatically mean something serious. Elevated levels can occur in benign liver conditions like cirrhosis or hepatitis. During pregnancy, moderately increased AFP might suggest a neural tube defect or multiple pregnancy. Significantly high levels warrant further investigation for potential liver cancer or germ cell tumors. Context matters tremendously in AFP interpretation.

What Low Levels May Indicate

In pregnancy screening, AFP levels lower than expected for gestational age can be associated with chromosomal abnormalities like Down syndrome. However, this is just one marker in a broader screening panel. Low AFP in non-pregnant adults is generally considered normal and not concerning.

Common Questions

Can I use this converter for pregnancy screening results?

Yes, but keep in mind that pregnancy AFP screening often uses MoM (multiples of the median) values adjusted for gestational age rather than absolute values. This converter handles the raw concentration values. Your obstetrician will interpret pregnancy screening results in the proper context with other markers.

Why do my results from two different labs show different values?

Even when using the same units, different laboratories may have slightly different reference ranges based on their testing methods and equipment. Small variations are normal. Significant differences should be discussed with your doctor to determine if they represent a real change or just methodological variation.

How accurate are these conversions?

The conversion factors used here are based on international standards and are highly accurate for converting between units. However, biological variability and testing methodology differences can affect the actual measured values. Use these conversions to compare units, not as medical advice.

Should I be worried if my AFP is slightly outside the normal range?

Not necessarily. Many factors can cause minor fluctuations. Your doctor will consider your complete medical history, physical examination, and other test results. Slightly elevated AFP can occur with benign liver conditions, recent alcohol consumption, or even pregnancy. Always discuss your results with a healthcare professional rather than trying to self-diagnose.

How often should AFP be monitored?

Monitoring frequency depends entirely on why you’re being tested. For cancer surveillance in high-risk patients, testing might occur every 3-6 months. During pregnancy, AFP is typically measured once as part of second-trimester screening. For liver disease monitoring, your hepatologist will determine the appropriate schedule based on your specific condition.

Can medications affect AFP levels?

Some medications and treatments can influence AFP levels, particularly those affecting liver function. Chemotherapy can cause temporary fluctuations. If you’re on any medications, inform your healthcare provider as they’ll factor this into their interpretation of your results.

What’s the difference between AFP-L3 and total AFP?

Total AFP measures all forms of the protein, while AFP-L3 is a specific variant that binds to a particular lectin. AFP-L3 percentage is particularly useful for distinguishing hepatocellular carcinoma from benign liver disease. This converter focuses on total AFP concentrations, but your doctor may order AFP-L3 testing for additional specificity.

Scenarios and Interpretations

Scenario 1: Adult Male with Liver Disease History

A 55-year-old man with chronic hepatitis C has an AFP level of 25 ng/mL (20.75 IU/mL). While this exceeds the typical adult reference range, it’s common in chronic liver disease. His doctor will monitor the trend over time. A rapid increase would be more concerning than a stable, mildly elevated level. Serial measurements matter more than a single data point.

Scenario 2: Pregnancy Screening

A pregnant woman at 18 weeks has an AFP level of 45 ng/mL (37.35 IU/mL). This needs to be evaluated in context with her gestational age, weight, and whether she has diabetes. The lab will calculate a MoM value comparing her result to the median for her specific situation. This isn’t something you can interpret from the raw number alone.

Scenario 3: Post-Treatment Monitoring

After surgery for a germ cell tumor, a patient’s AFP drops from 500 ng/mL to 8 ng/mL. This dramatic decrease suggests successful tumor removal. The oncologist will continue monitoring to ensure levels stay low, as any rise could indicate recurrence before imaging would detect it.

Scenario 4: Unexplained Elevation

An otherwise healthy person has an AFP of 35 ng/mL discovered incidentally. This prompts further workup including liver function tests, viral hepatitis screening, and possibly imaging. Sometimes elevated AFP leads to discovery of previously unknown liver conditions that benefit from early intervention.

Comparison With Other Tumor Markers

Marker Primary Use Normal Range When Used With AFP
hCG Pregnancy, germ cell tumors < 5 IU/L (non-pregnant) Combined for germ cell tumor staging
CEA Colorectal, pancreatic cancer < 3 ng/mL Helps distinguish tumor types
CA 19-9 Pancreatic, biliary cancer < 37 U/mL Differentiates hepatobiliary disease
LDH Tissue damage, tumors 140-280 U/L Provides prognostic information

No tumor marker works perfectly in isolation. AFP is most valuable when interpreted alongside other clinical findings, imaging results, and additional blood tests. Your medical team considers the complete picture rather than relying on a single number.

Potential Pitfalls

Common Misinterpretations

Jumping to conclusions from a single elevated test is a frequent mistake. AFP can fluctuate for benign reasons. Comparing values from different labs without accounting for methodology differences can be misleading. Forgetting that pregnancy dramatically affects AFP levels leads to unnecessary worry. Context always matters more than the absolute number.

When to Seek Clarification

If your result is marked as abnormal, ask your provider about the degree of elevation and what additional tests might be needed. When switching labs or healthcare systems, request copies of previous results to maintain continuity. If you’re pregnant and see a concerning result, remember that screening tests aren’t diagnostic—they identify who needs further evaluation.

Technical Considerations

Sample handling affects results. Hemolysis (red blood cell breakdown) can interfere with testing. Timing relative to recent medical procedures matters. If you suspect an error, repeating the test is reasonable. Laboratory errors are rare but do occur.

References

American Cancer Society. Alpha-fetoprotein (AFP) Tumor Marker Test. Atlanta: American Cancer Society; 2024.
National Cancer Institute. Tumor Markers in Common Use. Bethesda: National Institutes of Health; 2024.
American College of Obstetricians and Gynecologists. Screening for Fetal Chromosomal Abnormalities. ACOG Practice Bulletin No. 226. Obstet Gynecol. 2020;136:e48-69.
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182-236.
Lok AS, Sterling RK, Everhart JE, et al. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology. 2010;138(2):493-502.
Teratani T, Tomita K, Suzuki T, et al. Alpha-fetoprotein producing gastric cancer: A case report and review. World J Gastroenterol. 2015;21(20):6344-6349.
Clinical Laboratory Standards Institute. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory. CLSI guideline C28-A3c. Wayne, PA: CLSI; 2018.

Did you find this AFP converter helpful?

Scroll to Top